Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Camtek Ltd. stock logo
CAMT
Camtek
$155.84
+3.0%
$172.83
$62.88
$215.99
$7.14B1.61511,056 shs3,676 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.17
+1.3%
$1.43
$0.85
$2.73
$361.23M2.46.73 million shs59,188 shs
Revvity Inc. stock logo
RVTY
Revvity
$94.36
-1.6%
$90.39
$81.22
$118.30
$10.56B1.051.51 million shs1.05 million shs
10x Genomics stock logo
TXG
10x Genomics
$22.19
-0.4%
$21.43
$8.06
$26.44
$2.87B2.052.59 million shs1,296 shs
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Camtek Ltd. stock logo
CAMT
Camtek
-2.84%-13.35%-15.84%-3.95%+131.72%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
0.00%-10.16%-31.95%-29.45%+12.75%
Revvity Inc. stock logo
RVTY
Revvity
+0.42%-3.44%+2.16%-1.68%+1.82%
10x Genomics stock logo
TXG
10x Genomics
+3.92%+6.55%-14.53%+13.90%+149.61%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Camtek Ltd. stock logo
CAMT
Camtek
$155.84
+3.0%
$172.83
$62.88
$215.99
$7.14B1.61511,056 shs3,676 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.17
+1.3%
$1.43
$0.85
$2.73
$361.23M2.46.73 million shs59,188 shs
Revvity Inc. stock logo
RVTY
Revvity
$94.36
-1.6%
$90.39
$81.22
$118.30
$10.56B1.051.51 million shs1.05 million shs
10x Genomics stock logo
TXG
10x Genomics
$22.19
-0.4%
$21.43
$8.06
$26.44
$2.87B2.052.59 million shs1,296 shs
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Camtek Ltd. stock logo
CAMT
Camtek
-2.84%-13.35%-15.84%-3.95%+131.72%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
0.00%-10.16%-31.95%-29.45%+12.75%
Revvity Inc. stock logo
RVTY
Revvity
+0.42%-3.44%+2.16%-1.68%+1.82%
10x Genomics stock logo
TXG
10x Genomics
+3.92%+6.55%-14.53%+13.90%+149.61%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Camtek Ltd. stock logo
CAMT
Camtek
2.50
Moderate Buy$174.3311.87% Upside
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
1.80
Reduce$1.8357.37% Upside
Revvity Inc. stock logo
RVTY
Revvity
2.23
Hold$107.7314.17% Upside
10x Genomics stock logo
TXG
10x Genomics
2.20
Hold$23.174.40% Upside

Current Analyst Ratings Breakdown

Latest TXG, PACB, RVTY, and CAMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/18/2026
10x Genomics stock logo
TXG
10x Genomics
DowngradeStrong-BuyHold
5/14/2026
Camtek Ltd. stock logo
CAMT
Camtek
UpgradeHold (C-)Hold (C)
5/13/2026
Revvity Inc. stock logo
RVTY
Revvity
DowngradeSell (D+)Sell (D)
5/13/2026
Camtek Ltd. stock logo
CAMT
Camtek
Reiterated RatingOutperform$200.00
5/13/2026
Camtek Ltd. stock logo
CAMT
Camtek
Set Price Target$174.00
5/13/2026
Camtek Ltd. stock logo
CAMT
Camtek
Boost Price TargetEqual Weight$161.00 ➝ $163.00
5/13/2026
Camtek Ltd. stock logo
CAMT
Camtek
Boost Price TargetOutperform$180.00 ➝ $195.00
5/13/2026
Camtek Ltd. stock logo
CAMT
Camtek
Boost Price TargetOverweight$175.00 ➝ $185.00
5/13/2026
Camtek Ltd. stock logo
CAMT
Camtek
Boost Price TargetBuy$185.00 ➝ $200.00
5/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetEqual Weight$20.00 ➝ $22.00
5/12/2026
Camtek Ltd. stock logo
CAMT
Camtek
Boost Price TargetBuy$175.00 ➝ $190.00
(Data available from 5/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Camtek Ltd. stock logo
CAMT
Camtek
$499.09M14.31$3.36 per share46.34$14.89 per share10.47
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$160.01M2.26$0.80 per share1.46$0.01 per share116.50
Revvity Inc. stock logo
RVTY
Revvity
$2.86B3.69$8.71 per share10.83$64.39 per share1.47
10x Genomics stock logo
TXG
10x Genomics
$642.82M4.38N/AN/A$6.41 per share3.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Camtek Ltd. stock logo
CAMT
Camtek
$50.72M$0.87179.1239.863.759.63%22.26%11.70%8/4/2026 (Estimated)
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$546.38M-$0.43N/AN/AN/A-80.35%-571.06%-18.82%8/3/2026 (Estimated)
Revvity Inc. stock logo
RVTY
Revvity
$241.20M$2.0945.3115.752.068.26%8.00%4.83%7/27/2026 (Estimated)
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.17N/AN/AN/A-3.55%-2.86%-2.23%8/6/2026 (Estimated)

Latest TXG, PACB, RVTY, and CAMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026
Camtek Ltd. stock logo
CAMT
Camtek
$0.69$0.70+$0.01$0.63$120.15 million$121.66 million
5/7/2026Q1 2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.17-$0.12+$0.05-$0.03$39.94 million$37.18 million
5/7/2026Q1 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.29-$0.10+$0.19-$0.10$146.41 million$150.84 million
5/5/2026Q1 2026
Revvity Inc. stock logo
RVTY
Revvity
$1.02$1.06+$0.04$0.36$704.07 million$711.12 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Camtek Ltd. stock logo
CAMT
Camtek
$1.330.85%N/A152.87%N/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A
Revvity Inc. stock logo
RVTY
Revvity
$0.280.30%N/A13.40%N/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest TXG, PACB, RVTY, and CAMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2026
Revvity Inc. stock logo
RVTY
Revvity
quarterly$0.070.32%7/17/20267/17/20268/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Camtek Ltd. stock logo
CAMT
Camtek
0.71
8.35
7.46
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
5.65
4.87
Revvity Inc. stock logo
RVTY
Revvity
0.37
1.72
1.41
10x Genomics stock logo
TXG
10x Genomics
N/A
5.90
5.42

Institutional Ownership

CompanyInstitutional Ownership
Camtek Ltd. stock logo
CAMT
Camtek
41.93%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
Revvity Inc. stock logo
RVTY
Revvity
86.65%
10x Genomics stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Camtek Ltd. stock logo
CAMT
Camtek
79.40%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.40%
Revvity Inc. stock logo
RVTY
Revvity
0.85%
10x Genomics stock logo
TXG
10x Genomics
8.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Camtek Ltd. stock logo
CAMT
Camtek
40045.83 million9.44 millionOptionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730310.60 million303.15 millionOptionable
Revvity Inc. stock logo
RVTY
Revvity
11,000111.56 million110.61 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240126.96 million115.73 millionOptionable

Recent News About These Companies

10x Genomics (TXG) Q1 2026 Earnings Transcript
10x Genomics Q1 Earnings Call Highlights
10x Genomics: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Camtek stock logo

Camtek NASDAQ:CAMT

$155.84 +4.53 (+2.99%)
As of 09:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications. It also develops automatic defect classification, which provides automatic defect classification of color images utilizing deep learning techniques to reduce and eliminate manual verification. In addition, the company offers MicroProf AP, a wafer metrology tool for applications at 3D packaging process steps; MicroProf DI, an optical inspection tool that enables inspection of structured and unstructured wafers for manufacturing process; MicroProf FE, a 2D/3D wafer metrology tool that serve front end HVM fab; MicroProf FS, an wafer metrology tool configurable for wafer foundry; MicroProf PT for hybrid metrology applications to common panel sizes; MicroProf MHU metrology tool, a material handling unit for semiconductor, MEMS, sapphire, and LED industries; MicroProf TL, an optical surface measurement tool for fully automatic 3D surface measurements; MicroProf 100, a universal surface metrology tool for determination of topography and film and sample thickness; MicroProf 200, a measuring device for contactless and non-destructive characterization of surfaces and films; and MicroProf 300, a SurfaceSens technology for quality assurance, development, and manufacturing. It serves semiconductor manufacturers, outsourced semiconductor assembly and test, integrated device manufacturers, and wafer level packaging subcontractors. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal Haemek, Israel.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.16 +0.02 (+1.30%)
As of 09:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Revvity stock logo

Revvity NYSE:RVTY

$94.36 -1.52 (-1.58%)
As of 09:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$22.19 -0.10 (-0.44%)
As of 09:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.